Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
Condition(s):Bronchiolitis Obliterans Syndrome; Hematologic MalignancyLast Updated:October 19, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Bronchiolitis Obliterans Syndrome; Hematologic MalignancyLast Updated:October 19, 2022Recruiting
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:March 9, 2020Completed
Condition(s):Eosinophilic EsophagitisLast Updated:February 28, 2019Unknown status
Condition(s):Acute RhinosinusitisLast Updated:March 29, 2017Completed
Condition(s):Difficult Asthma; Severe Persistent Asthma; Hyperventilation SyndromeLast Updated:May 1, 2018Completed
Condition(s):Allergic Rhinitis; Tachyphylaxis; Rhinitis MedicamentosaLast Updated:April 12, 2019Completed
Condition(s):Polyp of Nasal SinusLast Updated:January 9, 2018Terminated
Condition(s):Rhinoconjunctivitis; Rhinitis; Conjunctivitis; AllergyLast Updated:March 3, 2017Completed
Condition(s):Hematopoietic Stem Cell Transplant (HSCT); Bronchiolitis Obliterans (BO)Last Updated:January 16, 2024Recruiting
Condition(s):Asthma; Bronchial Diseases; Respiratory Tract Infections; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Immune System DiseasesLast Updated:February 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.